Lithium salts as a treatment for COVID-19: Pre-clinical outcomes
COVID-19 치료제로서의 리튬염: 전임상 결과
Article
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 임상, 치료법, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 임상, 치료법, 치료제,
[키워드] advance
Anti-inflammatory
anti-SARS-CoV-2
Antiviral
antiviral properties
antiviral property
approach
approved drug
clinical trial
clinical trials
Concentration
controls
coronavirus disease
Coronavirus disease 2019
COVID-19
disease
dose-dependent manner
Effect
effective drug
effective drugs
Effects
evaluate
evaluated
Evidence
evidence of
experiment
glycogen
glycogen synthase
hamster
hamsters
identifying
Inflammation
inhibited
less
lithium
lung
Lungs
microscopic observation
Mortality
N protein
Nasopharyngeal swab
nasopharyngeal swabs
neutral red
outcome
patients
Pre-clinical trial
Replication
replication of SARS-CoV-2
SARS-CoV-2
SARS-CoV-2 virus
significantly higher
supernatant
supernatants
Support
therapeutic effect
Toxicity
treated
Treatment
viral control
Viral load
virus
[DOI] 10.1016/j.biopha.2022.112872 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.biopha.2022.112872 PMC 바로가기 [Article Type] Article